Literature DB >> 21905989

Gene therapy for psychiatric disorders.

Johannes Thome1, Frank Hässler, Vanna Zachariou.   

Abstract

There is no indication that gene therapy can be applied in psychiatric patients any time soon. However, there are several promising developments on the level of experimental neuroscience indicating that gene therapy approaches have an effect in animal models of several psychiatric disorders including drug addiction, affective disorders, psychoses and dementia, modifying behavioural parameters via interventions on the molecular and cellular level. However, before gene therapy in psychiatric disorders can be considered on the human level, not only neurobiological and technical problems need to be overcome, but also important ethical questions answered.

Entities:  

Mesh:

Year:  2011        PMID: 21905989      PMCID: PMC3394098          DOI: 10.3109/15622975.2011.601927

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  16 in total

Review 1.  Gene therapy in psychiatric disorders: too early, too complex?

Authors:  John F Neumaier
Journal:  Curr Opin Pharmacol       Date:  2003-02       Impact factor: 5.547

Review 2.  Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.

Authors:  L Barzon; M Zanusso; F Colombo; G Palù
Journal:  Cancer Gene Ther       Date:  2006-06       Impact factor: 5.987

3.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

4.  p11 and gene therapy for severe psychiatric disorders: a practical goal?

Authors:  Guang Chen; Roy Twyman; Husseini K Manji
Journal:  Sci Transl Med       Date:  2010-10-20       Impact factor: 17.956

5.  Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.

Authors:  Brian Alexander; Jennifer Warner-Schmidt; Therese Eriksson; Carol Tamminga; Margarita Arango-Lievano; Margarita Arango-Llievano; Subroto Ghose; Mary Vernov; Mihaela Stavarache; Mihaela Stavarche; Sergei Musatov; Marc Flajolet; Per Svenningsson; Paul Greengard; Michael G Kaplitt
Journal:  Sci Transl Med       Date:  2010-10-20       Impact factor: 17.956

Review 6.  Gene transfer to the brain: emerging therapeutic strategy in psychiatry?

Authors:  K P Lesch
Journal:  Biol Psychiatry       Date:  1999-02-01       Impact factor: 13.382

7.  Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice.

Authors:  Niki C Carty; Kevin Nash; Daniel Lee; Mary Mercer; Paul E Gottschall; Craig Meyers; Nicholas Muzyczka; Marcia N Gordon; Dave Morgan
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

Review 8.  Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS.

Authors:  A Martinez-Serrano; F J Rubio; B Navarro; C Bueno; A Villa
Journal:  Curr Gene Ther       Date:  2001-09       Impact factor: 4.391

9.  Gene therapy reduces ethanol intake in an animal model of alcohol dependence.

Authors:  Paula Ocaranza; María Elena Quintanilla; Lutske Tampier; Eduardo Karahanian; Amalia Sapag; Yedy Israel
Journal:  Alcohol Clin Exp Res       Date:  2007-12-07       Impact factor: 3.455

Review 10.  Gene therapy for psychiatric disorders.

Authors:  Robert M Sapolsky
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

View more
  1 in total

Review 1.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.